



Background: Obesity, a prominent risk factor for endometrial cancer development and public health issue, affects nearly one-third of the US population; bariatric surgery is an alternative weight loss option. Little is known of how bariatric surgery-related weight loss affects other obesity-aggravating factors, such as daytime sleepiness and depression. This study is among the first to look at the effects of bariatric surgery-related BMI reduction on daytime sleepiness and depressive symptoms among women. 
Objective: To gauge the effect of bariatric surgery on daytime sleepiness, depressive symptoms, and BMI. 
Methods: As part of a larger study ("Effects of weight loss on biomarkers of immunity and inflammation: Implications for endometrial cancer risk" Linkov, PI), 51 women completed the Epworth Sleepiness Scale and Center for Epidemiologic Studies Depression Scale and had anthropometric measurements recorded pre- and post-bariatric surgery at Magee-Womens Hospital. Paired sample t-tests analyzed changes between baseline (before surgery) and post-surgery follow-up (mean follow-up time=7.18 months, SD=2.40). Participants were then separated into groups based on BMI lost, using median BMI lost (median=12.20). Linear regression was used to test the significance of relationships pre-/post-surgery between BMI and depressive symptoms and daytime sleepiness, as well as relationships between daytime sleepiness and depressive symptoms.
Results: Our sample consisted of 51 obese women (85.7% white, mean age=43.51±11.94 years, mean BMI=46.35±5.58). Improvements were seen between baseline and post-surgery follow-up in: daytime sleepiness (m=-1.21±3.39, p=0.014), total CES-D score (m=-3.00±8.57, p=0.016), likelihood of meeting CES-D score criteria for clinical depression (p=0.031), and BMI (m=-11.94±4.46, p<0.001). Controlling for baseline BMI, age, and race, BMI change was not significantly associated with depressive symptoms change (p=0.558) or daytime sleepiness change (p=0.274). However, daytime sleepiness change was significantly associated with depressive symptoms change (p=0.042).
Conclusion: With the growing burden of obesity, there is a need to understand the underlying mechanisms of obesity aggravating factors. Bariatric surgery significantly reduced daytime sleepiness and depressive symptoms, which are common obesity-aggravating factors. These findings may have implications for women undergoing bariatric surgery to reduce their risks of developing endometrial cancer and other obesity-related diseases, as well as suggest new areas of concern for healthcare providers in this setting.
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Endometrial cancer is the most common gynecologic cancer among women.1 For 2013, the expected number of new cases in the US are 49,560, and about 8,190 will die from endometrial cancer, which has been steadily increasing from estimates in previous years., 90% of cases occur in women over 50 years of age, and about 20% of women will be diagnosed before menopause. There are four stages of endometrial cancer with stage IV as the most advance disease, and roughly 72% are stage I, 12% stage II, 13% stage III, and 3% stage IV.3 
Endometrial cancer can spread in the body through tissue (cancer invades surrounding tissues), the lymph system (travels using the lymph vessels to other places in the body), and blood (cancer invades the veins and capillaries, traveling through the bloodstream to other places in the body). These three methods of spreading determine the stage of endometrial cancer. In stage I, the cancer is found only in the uterus. In stage II, the cancer has spread to the connective tissue of the cervix but not outside the uterus. In stage III, the cancer has spread beyond the uterus and cervix, but not past the pelvis. In stage IV, the cancer has spread past the pelvis. Stages I and IV can be classified using A or B depending on how far the cancer has spread, and Stage III can be classified as A, B, or C dependent on the spread. Type A is designated as the least amount of spread, and type C is designated as the most amount of spread before reaching the next stage. HYPERLINK \l "_ENREF_4" \o "National Cancer Institute, 2013 #87"  ADDIN EN.CITE <EndNote><Cite><Author>National Cancer Institute</Author><Year>2013</Year><RecNum>87</RecNum><DisplayText><style face="superscript">4</style></DisplayText><record><rec-number>87</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1381292012">87</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors><authors><author>National Cancer Institute,</author></authors></contributors><titles><title>Stages of Endometrial Cancer</title></titles><dates><year>2013</year></dates><publisher>National Institutes of Health</publisher><urls><related-urls><url>http://www.cancer.gov/cancertopics/pdq/treatment/endometrial/Patient/page2</url></related-urls></urls></record></Cite></EndNote>4
Risk factors for endometrial cancer can range from genetic factors all the way to lifestyle choices. Changes in hormones, such as estrogen therapy and menopause, is one type of risk factor of endometrial cancer. Obesity, which is the leading cause of morbidity and mortality in the US, HYPERLINK \l "_ENREF_5" \o "Hedley, 2004 #55"  ADDIN EN.CITE <EndNote><Cite><Author>Hedley</Author><Year>2004</Year><RecNum>55</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>55</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380929012">55</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hedley, A. A.</author><author>Ogden, C. L.</author><author>Johnson, C. L.</author><author>Carroll, M. D.</author><author>Curtin, L. R.</author><author>Flegal, K. M.</author></authors></contributors><titles><title>Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002</title><secondary-title>JAMA</secondary-title></titles><periodical><full-title>JAMA</full-title></periodical><pages>2847-2850</pages><volume>291</volume><dates><year>2004</year></dates><urls></urls></record></Cite></EndNote>5 also has a strong association with endometrial cancer. Obese women have an increased risk (RR=1.85, 95% CI=1.30 to 2.65) of endometrial cancer compared to women of normal weight. HYPERLINK \l "_ENREF_6" \o "Dobbins, 2013 #88"  ADDIN EN.CITE <EndNote><Cite><Author>Dobbins</Author><Year>2013</Year><RecNum>88</RecNum><DisplayText><style face="superscript">6</style></DisplayText><record><rec-number>88</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1381293135">88</key><key app="ENWeb" db-id="">0</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dobbins, M.</author><author>Decorby, K.</author><author>Choi, B. C. K.</author></authors></contributors><titles><title>The association between obesity and cancer risk: A meta-analysis of observational studies from 1985 to 2011</title><secondary-title>ISRN Preventive Med</secondary-title></titles><periodical><full-title>ISRN Preventive Med</full-title></periodical><pages>1-16</pages><volume>2013</volume><dates><year>2013</year></dates><isbn>2090-8784</isbn><urls></urls><electronic-resource-num>10.5402/2013/680536</electronic-resource-num></record></Cite></EndNote>6 Other risk factors for endometrial cancer include age, diet and exercise, diabetes, family history of endometrial cancer, previous pelvic radiation, previous breast or ovarian cancer, and endometrial hyperplasia, which is an increased growth of the endometrium.,
1.2	OBESITY
Over one-third of US adults are obese, and the estimated annual medical cost of obesity in the US was $147 billion in the US in 2008. HYPERLINK \l "_ENREF_7" \o "Centers for Disease Control and Prevention, 2013 #196"  ADDIN EN.CITE <EndNote><Cite><Author>Centers for Disease Control and Prevention</Author><Year>2013</Year><RecNum>196</RecNum><DisplayText><style face="superscript">7</style></DisplayText><record><rec-number>196</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1386213801">196</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors><authors><author>Centers for Disease Control and Prevention,</author></authors></contributors><titles><title>Adult obesity facts</title></titles><dates><year>2013</year></dates><urls><related-urls><url>http://www.cdc.gov/obesity/data/adult.html</url></related-urls></urls></record></Cite></EndNote>7 The World Health Organization defines obesity as a BMI greater than or equal to 30. HYPERLINK \l "_ENREF_8" \o "World Health Organization, 2013 #199"  ADDIN EN.CITE <EndNote><Cite><Author>World Health Organization</Author><Year>2013</Year><RecNum>199</RecNum><DisplayText><style face="superscript">8</style></DisplayText><record><rec-number>199</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1386217151">199</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors><authors><author>World Health Organization,</author></authors></contributors><titles><title>Obesity and overweight</title></titles><dates><year>2013</year></dates><urls><related-urls><url>http://www.who.int/mediacentre/factsheets/fs311/en/</url></related-urls></urls></record></Cite></EndNote>8 Obesity is the leading cause of morbidity and mortality in the US and has been linked to numerous conditions such as heart disease, stroke, type 2 diabetes, and certain types of cancer, such as endometrial cancer., Obesity has also been found to be correlated to loss of life expectancy. For example, in comparison with a normal-weight individual, a 25 year old morbidly obese man has a 22% reduction in expected remaining lifespan. HYPERLINK \l "_ENREF_9" \o "Fontaine, 2003 #200"  ADDIN EN.CITE <EndNote><Cite><Author>Fontaine</Author><Year>2003</Year><RecNum>200</RecNum><DisplayText><style face="superscript">9</style></DisplayText><record><rec-number>200</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1386218946">200</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fontaine, K. R.</author><author>Redden, D. T.</author><author>Wang, C.</author><author>Westfall, A. O.</author><author>Allison, D. B.</author></authors></contributors><titles><title>Years of life lost due to obesity</title><secondary-title>JAMA</secondary-title></titles><periodical><full-title>JAMA</full-title></periodical><pages>187-193</pages><volume>289</volume><dates><year>2003</year></dates><urls></urls></record></Cite></EndNote>9 Treatment methods for obesity have been studied frequently, but there is still controversy over treatment methods.
Treatment methods for obesity range from lifestyle changes, focusing on diet and exercise as prime factors, to surgical methods, such as bariatric surgery. HYPERLINK \l "_ENREF_10" \o "National Heart Lung and Blood Institute, 2012 #197"  ADDIN EN.CITE <EndNote><Cite><Author>National Heart Lung and Blood Institute</Author><Year>2012</Year><RecNum>197</RecNum><DisplayText><style face="superscript">10</style></DisplayText><record><rec-number>197</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1386215671">197</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors><authors><author>National Heart Lung and Blood Institute,</author></authors></contributors><titles><title>How are overweight and obesity treated?</title></titles><dates><year>2012</year></dates><urls><related-urls><url>http://www.nhlbi.nih.gov/health/health-topics/topics/obe/treatment.html</url></related-urls></urls></record></Cite></EndNote>10 Despite predicted growth of bariatric surgery due to high prevalence of obesity, the incidence of bariatric surgery has plateaued in the US with approximately 113,000 cases per year. HYPERLINK \l "_ENREF_11" \o "Livingston, 2010 #198"  ADDIN EN.CITE <EndNote><Cite><Author>Livingston</Author><Year>2010</Year><RecNum>198</RecNum><DisplayText><style face="superscript">11</style></DisplayText><record><rec-number>198</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1386216824">198</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Livingston, E. H.</author></authors></contributors><titles><title>The incidence of bariatric surgery has plateaued in the U.S.</title><secondary-title>Am J Surg</secondary-title></titles><periodical><full-title>Am J Surg</full-title></periodical><pages>378-385</pages><volume>200</volume><number>3</number><dates><year>2010</year></dates><urls></urls></record></Cite></EndNote>11 Although incidence of bariatric surgery has not increased at the same rate as obesity, bariatric surgery is still a common alternative method for weight loss, particularly in those for whom lifestyle changes did not work.
1.3	OBESITY AND depression
Depression is the most common mental health disorder in the US with a lifetime prevalence of 16.6%., Depression has been found to be significantly associated with obesity in that those who were obese were more likely to also be depressed., Dixon et al. found obesity and depression have an additive effect on one another, basically feeding into an increase in both depression and weight. HYPERLINK \l "_ENREF_13" \o "Dixon, 2003 #58"  ADDIN EN.CITE <EndNote><Cite><Author>Dixon</Author><Year>2003</Year><RecNum>58</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>58</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380930270">58</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dixon, J. B.</author><author>Dixon, M. E.</author><author>O&apos;Brien, P. E.</author></authors></contributors><titles><title>Depression in association with severe obesity</title><secondary-title>Arch Intern Med</secondary-title></titles><periodical><full-title>Arch Intern Med</full-title><abbr-1>Archives of Internal Medicine</abbr-1></periodical><pages>2058-2065</pages><volume>163</volume><dates><year>2003</year></dates><urls></urls></record></Cite></EndNote>13 Bariatric surgery has been found to improve depressive symptoms and depression levels overall in obese individuals. ADDIN EN.CITE , Faulconbridge et al. found that bariatric surgery has similar improvements in mood, depression, and quality of life that can be also expected from lifestyle modification treatments. HYPERLINK \l "_ENREF_16" \o "Faulconbridge, 2013 #86"  ADDIN EN.CITE <EndNote><Cite><Author>Faulconbridge</Author><Year>2013</Year><RecNum>86</RecNum><DisplayText><style face="superscript">16</style></DisplayText><record><rec-number>86</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1381291159">86</key><key app="ENWeb" db-id="">0</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Faulconbridge, L. F.</author><author>Wadden, T. A.</author><author>Thomas, J. G.</author><author>Jones-Corneille, L. R.</author><author>Sarwer, D. B.</author><author>Fabricatore, A. N.</author></authors></contributors><auth-address>Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania. Electronic address: lucyhf@mail.med.upenn.edu.</auth-address><titles><title>Changes in depression and quality of life in obese individuals with binge eating disorder: Bariatric surgery versus lifestyle modification</title><secondary-title>Surg Obes Relat Dis</secondary-title><alt-title>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</alt-title></titles><periodical><full-title>Surg Obes Relat Dis</full-title><abbr-1>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</abbr-1></periodical><alt-periodical><full-title>Surg Obes Relat Dis</full-title><abbr-1>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</abbr-1></alt-periodical><pages>790-796</pages><volume>9</volume><number>5</number><dates><year>2013</year><pub-dates><date>September - October</date></pub-dates></dates><isbn>1878-7533 (Electronic)&#xD;1550-7289 (Linking)</isbn><accession-num>23260806</accession-num><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23260806</url></related-urls></urls><custom2>3609883</custom2><electronic-resource-num>10.1016/j.soard.2012.10.010</electronic-resource-num></record></Cite></EndNote>16
1.4	OBESITY AND Daytime sleepiness
In the U.S., obesity has been on the rise, HYPERLINK \l "_ENREF_17" \o "Cizza, 2011 #54"  ADDIN EN.CITE <EndNote><Cite><Author>Cizza</Author><Year>2011</Year><RecNum>54</RecNum><DisplayText><style face="superscript">17</style></DisplayText><record><rec-number>54</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380928886">54</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cizza, G.</author><author>Requena, M.</author><author>Galli, G.</author><author>de Jonge, L.</author></authors></contributors><titles><title>Chronic sleep deprivation and seasonality: Implications for the obesity epidemic</title><secondary-title>J Endocrinol Invest</secondary-title></titles><periodical><full-title>J Endocrinol Invest</full-title><abbr-1>Journal of Endocrinological Investigation</abbr-1></periodical><pages>793-800</pages><volume>34</volume><number>10</number><dates><year>2011</year></dates><urls></urls></record></Cite></EndNote>17 and chronic sleep deprivation has followed suit. ADDIN EN.CITE 18\o "Hedley, 2004 #55" Chronic sleep deprivation can occur through either fewer number of hours of sleep or through poor quality of sleep. Poor sleep quality can have very adverse effects on functional and cognitive function. Spira et al. found that for older women both a shorter sleep duration and lower sleep efficiency are risk factors for functional, as well as physical decline. HYPERLINK \l "_ENREF_19" \o "Spira, 2012 #81"  ADDIN EN.CITE <EndNote><Cite><Author>Spira</Author><Year>2012</Year><RecNum>81</RecNum><DisplayText><style face="superscript">19</style></DisplayText><record><rec-number>81</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1381282426">81</key><key app="ENWeb" db-id="">0</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Spira, A. P.</author><author>Covinsky, K.</author><author>Rebok, G. W.</author><author>Punjabi, N. M.</author><author>Stone, K. L.</author><author>Hillier, T. A.</author><author>Ensrud, K. E.</author><author>Yaffe, K.</author></authors></contributors><titles><title>Poor sleep quality and functional decline in older women</title><secondary-title>J Am Geriatr Soc</secondary-title></titles><periodical><full-title>J Am Geriatr Soc</full-title></periodical><pages>1092-1098</pages><volume>60</volume><number>6</number><dates><year>2012</year></dates><urls></urls></record></Cite></EndNote>19 One method of measuring quality of sleep is through measuring average sleep propensity in daily life, also known as daytime sleepiness. HYPERLINK \l "_ENREF_20" \o "Johns, 1991 #48"  ADDIN EN.CITE <EndNote><Cite><Author>Johns</Author><Year>1991</Year><RecNum>48</RecNum><DisplayText><style face="superscript">20</style></DisplayText><record><rec-number>48</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380760937">48</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Johns, M. W.</author></authors></contributors><titles><title>A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale</title><secondary-title>SLEEP</secondary-title><alt-title>SLEEP</alt-title></titles><periodical><full-title>Sleep</full-title></periodical><alt-periodical><full-title>Sleep</full-title></alt-periodical><pages>540-545</pages><volume>14</volume><dates><year>1991</year></dates><urls></urls></record></Cite></EndNote>20 Daytime sleepiness is defined as a person's average sleep propensity in daily life or one's tendency to feel sleepy during daily activities. HYPERLINK \l "_ENREF_20" \o "Johns, 1991 #48"  ADDIN EN.CITE <EndNote><Cite><Author>Johns</Author><Year>1991</Year><RecNum>48</RecNum><DisplayText><style face="superscript">20</style></DisplayText><record><rec-number>48</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380760937">48</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Johns, M. W.</author></authors></contributors><titles><title>A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale</title><secondary-title>SLEEP</secondary-title><alt-title>SLEEP</alt-title></titles><periodical><full-title>Sleep</full-title></periodical><alt-periodical><full-title>Sleep</full-title></alt-periodical><pages>540-545</pages><volume>14</volume><dates><year>1991</year></dates><urls></urls></record></Cite></EndNote>20
Daytime sleepiness has been found to be strongly associated with both obesity and depression, independently,, and recent research indicates that together, obesity and depression may have compounding effects on daytime sleepiness. HYPERLINK \l "_ENREF_14" \o "Bixler, 2005 #59"  ADDIN EN.CITE <EndNote><Cite><Author>Bixler</Author><Year>2005</Year><RecNum>59</RecNum><DisplayText><style face="superscript">14</style></DisplayText><record><rec-number>59</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380930849">59</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bixler, E. O., </author><author>Vgontzas, A. N., </author><author>Lin, H. M., </author><author>Calhoun, S. L., </author><author>Vela-Bueno, A., </author><author>Kales, A.</author></authors></contributors><titles><title>Excessive daytime sleepiness in a general population sample: The role of slep apnoea, age, obesity, diabetes and depression</title><secondary-title>J Clin Endocrinol Metab</secondary-title></titles><periodical><full-title>J Clin Endocrinol Metab</full-title></periodical><pages>4510-4515</pages><volume>90</volume><number>8</number><dates><year>2005</year></dates><urls></urls></record></Cite></EndNote>14 Bariatric surgery has been found to improve daytime sleepiness and sleep overall, which is no surprise due to the strong associations with obesity. ADDIN EN.CITE , Most studies that have looked at the effects of obesity on sleepiness have involved samples of men and women drawn from the general population. Few studies have explored daytime sleepiness in morbidly obese women undergoing bariatric surgery. 
1.5	present study
Previous research has linked obesity to increasing risk in endometrial cancer, but little research has been done until recently to examine how daytime sleepiness and depression may jointly be linked with adverse effects of obesity on health. Other studies have found that depression may act as an aggravating co-morbid disorder, which the relationship has shown that obesity can also aggravate depressive symptoms. ADDIN EN.CITE 13-15 Daytime sleepiness plays a role in both depression\o "Calhoun, 2011 #56" and obesity. ADDIN EN.CITE ,, Daytime sleepiness can cause an increase in depressive symptoms as well as an increase in obesity. 
Bariatric surgery is already known to reduce symptoms associated with obesity, HYPERLINK \l "_ENREF_24" \o "Sjöström, 2009 #83"  ADDIN EN.CITE <EndNote><Cite><Author>Sjöström</Author><Year>2009</Year><RecNum>83</RecNum><DisplayText><style face="superscript">24</style></DisplayText><record><rec-number>83</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1381287235">83</key><key app="ENWeb" db-id="">0</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sjöström, L.</author><author>Gummesson, A.</author><author>Sjöström, C. D.</author><author>Narbro, K.</author><author>Peltonen, M.</author><author>Wedel, H.</author><author>Bengtsson, C.</author><author>Bouchard, C.</author><author>Carlsson, B.</author><author>Dahlgren, S.</author><author>Jacobson, P.</author><author>Karason, K.</author><author>Karlsson, J.</author><author>Larsson, B.</author><author>Lindroos, A.</author><author>Lönroth, H.</author><author>Näslund, I.</author><author>Olbers, T.</author><author>Stenlöf, K.</author><author>Torgerson, J.</author><author>Carlsson, L. M. S.</author></authors></contributors><titles><title>Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective, controlled intervention trial</title><secondary-title>Lancet Oncol</secondary-title></titles><periodical><full-title>Lancet Oncol</full-title></periodical><pages>653-662</pages><volume>10</volume><number>7</number><dates><year>2009</year></dates><urls></urls><electronic-resource-num>10.1016/s14702045(09)70159-7</electronic-resource-num></record></Cite></EndNote>24 and separate studies in the literature have shown that daytime sleepiness ADDIN EN.CITE , and depression HYPERLINK \l "_ENREF_13" \o "Dixon, 2003 #58"  ADDIN EN.CITE <EndNote><Cite><Author>Dixon</Author><Year>2003</Year><RecNum>58</RecNum><DisplayText><style face="superscript">13</style></DisplayText><record><rec-number>58</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380930270">58</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dixon, J. B.</author><author>Dixon, M. E.</author><author>O&apos;Brien, P. E.</author></authors></contributors><titles><title>Depression in association with severe obesity</title><secondary-title>Arch Intern Med</secondary-title></titles><periodical><full-title>Arch Intern Med</full-title><abbr-1>Archives of Internal Medicine</abbr-1></periodical><pages>2058-2065</pages><volume>163</volume><dates><year>2003</year></dates><urls></urls></record></Cite></EndNote>13 are reduced after bariatric surgery. However, this is one of the first studies to look at the effects of bariatric surgery on BMI, daytime sleepiness, and depressive symptoms in the same sample. The purpose of this study was to determine the effects of bariatric surgery on daytime sleepiness, depressive symptoms, and BMI. In addition, the study examined possible relationships between these three variables. We hypothesized that these obesity-aggravating factors and the main endometrial cancer risk factor, obesity, would decrease significantly post-surgery. We also hypothesized that change in daytime sleepiness would act as a mediator between change in BMI and change in depressive symptoms (Figure 1).





Participants were obese women undergoing bariatric surgery at Magee-Womens Hospital from 2010 to 2013. Participants were identified from a larger study focusing on cancer associated biomarkers and endometrial health. Women were eligible to participate if they met all the requirements for bariatric surgery, signed informed consent, and were not planning to move within 2 years of their bariatric surgery. The parent study was limited to women, as preliminary evidence demonstrates that weight loss has a greater potential to influence cancer risk in female participants. HYPERLINK \l "_ENREF_24" \o "Sjöström, 2009 #83"  ADDIN EN.CITE <EndNote><Cite><Author>Sjöström</Author><Year>2009</Year><RecNum>83</RecNum><DisplayText><style face="superscript">24</style></DisplayText><record><rec-number>83</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1381287235">83</key><key app="ENWeb" db-id="">0</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sjöström, L.</author><author>Gummesson, A.</author><author>Sjöström, C. D.</author><author>Narbro, K.</author><author>Peltonen, M.</author><author>Wedel, H.</author><author>Bengtsson, C.</author><author>Bouchard, C.</author><author>Carlsson, B.</author><author>Dahlgren, S.</author><author>Jacobson, P.</author><author>Karason, K.</author><author>Karlsson, J.</author><author>Larsson, B.</author><author>Lindroos, A.</author><author>Lönroth, H.</author><author>Näslund, I.</author><author>Olbers, T.</author><author>Stenlöf, K.</author><author>Torgerson, J.</author><author>Carlsson, L. M. S.</author></authors></contributors><titles><title>Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective, controlled intervention trial</title><secondary-title>Lancet Oncol</secondary-title></titles><periodical><full-title>Lancet Oncol</full-title></periodical><pages>653-662</pages><volume>10</volume><number>7</number><dates><year>2009</year></dates><urls></urls><electronic-resource-num>10.1016/s14702045(09)70159-7</electronic-resource-num></record></Cite></EndNote>24 
2.2	DESIGN
This is a longitudinal study examining changes in BMI, depressive symptoms and diagnosis, and daytime sleepiness before and after bariatric surgery. All study participants completed the Epworth Sleepiness Scale (ESS) and Center for Epidemiologic Studies Depression Scale (CES-D) before and after bariatric surgery; anthropometric measurements were also recorded at both visits. Pre-bariatric surgery times ranged from 2 days before bariatric surgery to 17 months before bariatric surgery, with a mean pre-bariatric surgery time of 2.06 months (SD=3.64). Follow-up times after bariatric surgery ranged from 5 months to 17 months, which is the time period where participants lose the highest number of BMI points, with a mean follow-up time of 7.18 months (SD=2.40).
2.3	Procedure
2.3.1	Measures
Daytime sleepiness was assessed with the Epworth Sleepiness Scale (ESS). The ESS20 is a short, self-report questionnaire that measured the participant's general level of daytime sleepiness. It had participants rate, on a 4-point Likert scale (0 to 3), the chance of falling asleep in 8 different activities that most people engage in during their daily lives. Participants can score between a range of 0 to 24; a score between 0 and 9 is considered normal while a score between 10 and 24 is considered indicative of mild to severe sleep apnea. The ESS has a high level of internal consistency with a Cronbach's alpha of 0.88.25
Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D). The CES-D is a 20-item questionnaire that measured depressive symptomatology in the general population using a 4-point Likert scale (0 to 3). Total scores can range from 0 to 60. HYPERLINK \l "_ENREF_26" \o "Radloff, 1977 #61"  ADDIN EN.CITE <EndNote><Cite><Author>Radloff</Author><Year>1977</Year><RecNum>61</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>61</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380932335">61</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Radloff, L.S.</author></authors></contributors><titles><title>The CES-D scale: A self report depression scale for research in the general population</title><secondary-title>App Psych Meas</secondary-title></titles><periodical><full-title>App Psych Meas</full-title></periodical><pages>385-401</pages><volume>1</volume><number>3</number><dates><year>1977</year></dates><urls></urls></record></Cite></EndNote>26 A score of 16 or more is identified as clinically meaningful depression. The internal consistency has been tested numerous times with results ranging from a Cronbach's α of 0.85 to 0.92. HYPERLINK \l "_ENREF_27" \o "Carleton, 2013 #62"  ADDIN EN.CITE <EndNote><Cite><Author>Carleton</Author><Year>2013</Year><RecNum>62</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>62</rec-number><foreign-keys><key app="EN" db-id="papdwataw9s299e5aw2p22rq55555tvxx2dz" timestamp="1380932825">62</key><key app="ENWeb" db-id="">0</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Carleton, R. N.</author><author>Thibodeau, M. A.</author><author>Teale, M. J. N.</author><author>Welch, P. G.</author><author>Abrams, M. P.</author><author>Robinson, T.</author><author>Asmundson, G. J. G.</author></authors></contributors><titles><title>The center for epidemiologic studies depression scale: A review with a theoretical and empirical examination of item content and factor structure</title><secondary-title>PLOS One</secondary-title></titles><periodical><full-title>PLOS One</full-title></periodical><pages>1-11</pages><volume>8</volume><number>3</number><dates><year>2013</year></dates><urls></urls><electronic-resource-num>10.1371/journal.pone.0058067.t001</electronic-resource-num></record></Cite></EndNote>27 In a study focusing on depressed postpartum women, the CES-D was found to have a sensitivity of 60%, specificity of 92%, and positive predictive value of 53%.28 Four specific individual items ("I felt that I was just as good as other people," "I felt hopeful about the future," "I was happy," and "I enjoyed life") were chosen to be more closely analyzed in addition to the overall scale because they seemed more closely associated with happiness and perception of personal image.
Anthropometric measures were assessed by the Tanita Reading Scale. The Tanita Reading Scale (Tanita Corporation of America, Inc., IL) is a digital scale that provides anthropometric measurements such as BMI, weight, height fat mass, fat percent, etc. For the purpose of these analyses, only BMI (derived from weight and height measurements) was used.
Demographic characteristics of the participants were also assessed with a General Characteristics Questionnaire. This is a basic questionnaire that asked participants for their date of birth, age, race, highest education received, and income.
2.4	data analySIS technique
Descriptive statistics were used to illustrate participant characteristics at baseline (Table 1). Age, BMI, and waist-hip ratio were continuous variables; race (white/other) was a dichotomous variable. Paired sample t-tests were used to test the significance of changes in BMI, daytime sleepiness, and depressive symptoms between baseline visit (before surgery) and a post-surgery follow-up.  Participants were then stratified into groups based on BMI lost, using the median BMI lost as the determining factor (Small BMI loss group = BMI of 12.20 or less lost, Big BMI loss group = BMI of greater than 12.20 lost).  Linear regression was used to test the significance of relationships at baseline between total depressive symptoms on BMI, total depressive symptoms on daytime sleepiness, and daytime sleepiness on BMI.
3.0 	results
As shown in Table 1, the majority of the participants were white with an average age of 43.51. At baseline, participants had a mean weight of 272.79 lbs (SD=42.00, range=192.50-386.50). The mean weight of participants at their follow-up visit was 202.61 lbs (SD=40.96, range=116.00-317.00).

Table 1. Participant characteristics
Characteristic	N	Mean ± SD or N (%)
Age (years)	51	45.63 ± 11.60
		
Race (%)		
     White	49	42 (85.7)
     Other	49	7 (14.3)
		
Gender (%)		
   Female		51 (100.0)
		
Weight at baseline (lbs)	51	272.79 ± 42.00











Grade school (grades 1-8)	50	1 (2.0)
High school (grades 9-12)	50	11 (22.0)
Earned G.E.D. (Graduate Equivalent Diploma)	50	3 (6.0)
Vocational/Technical school certificate	50	6 (12.0)
2-year college (Associates level)	50	12 (24.0)
4-year college (Bachelors level)	50	11 (22.0)








Household gross annual income		
Under $10,000	42	3 (7.1)
$10,000 to $14,999	42	3 (7.1)
$15,000 to $19,999	42	2 (4.8)
$20,000 to $29,999	42	5 (11.9)
$30,000 to $39,999	42	3 (7.1)
$40,000 to $49,999	42	7 (16.7)
$50,000 to $59,999	42	2 (4.8)
$60,000 to $69,999	42	4 (9.5)
$70,000 to $79,999	42	3 (7.1)
$80,000 to $99,999	42	4 (9.5)
$100,000 to $150,000	42	6 (14.3)
Note. Some participants chose to not answer certain parts of the general questionnaire, such as race, income, and education.





           Table 2. Summary statistics of BMI, Epworth Sleepiness, and Depression scores
Variable	N	Baseline (Mean ± SD)	Follow-up (Mean ± SD)	Pre to Post Change (Mean ± SD)	p-value
BMI	51	46.35 ± 5.58	34.40 ± 5.45	-11.94 ± 4.46	<0.001
					
Total ESS	51	7.10 ± 4.77	5.89 ± 4.22	-1.21 ± 3.39	0.014
					
CES-D Meet diagnosis criterion	51	15 (29.4%)	7 (13.7%)	8 (53.3%)	0.031
CES-D					
Total score	51	12.16 ± 9.15	9.16 ± 8.94	-3.00 ± 8.57	0.016
I felt that I was just as good as other people	51	0.59 ± 0.94	0.51 ± 0.76	-0.08 ± 1.02	0.584
I felt hopeful about the future	51	0.75 ± 1.00	0.67 ± 0.95	0.08 ± 1.32	0.674
I was happy	51	0.76 ± 0.91	0.45 ± 0.70	-0.31 ± 0.79	0.006
I enjoyed life	51	0.80 ± 0.92	0.41 ± 0.70	-0.39 ± 0.78	0.001


Figure 2. Baseline and follow-up BMI

Figure 3. Baseline and follow-up daytime sleepiness 


Figure 4. Baseline and follow-up CES-D individual items


Figure 5. Baseline and follow-up CES-D score


Figure 6. Baseline and follow-up percentage of participants with CES-D scores meeting diagnosis levels for depression

At baseline, 15 (29.4%) participants had CES-D scores that met the diagnosis criterion for depression, which reduced to 7 (13.7%) participants at their follow-up. Using the ESS at baseline, 14 (27.5%) scored 10 or higher, indicating that they had significant issues with daytime sleepiness. At the follow-up, this number dropped to 11 (21.6%); however, the highest ESS score at follow-up was only 16 whereas the highest score at baseline was 21, suggesting that there was some overall improvement in daytime sleepiness.
As an additional analysis, participants were separated into groups based on BMI points lost, using the median BMI lost as the determining factor (Small BMI loss group = BMI of 12.20 or less lost, Big BMI loss group = BMI of greater than 12.20 lost). Daytime sleepiness, CES-D criterion for depression met, total depressive symptoms, and CES-D individual items were analyzed using paired samples t-tests (Table 3). 
Table 3. Group comparison based on BMI points lost (Median Split): Summary statistics of           
               BMI, Epworth Sleepiness, and Depression Scores

Variable	N	Baseline (Mean ± SD)	Follow-up (Mean ± SD)	Pre to Post Change (Mean ± SD)	p-value
Small BMI loss group (lost 12.20 points or less)					
     BMI	26	44.14 ± 4.59	35.27 ± 5.34	-8.87 ± 3.31	<0.001
					
     Total ESS	26	6.96 ± 4.09	5.66 ± 3.97	-1.30 ± 3.20	0.049
					
     CES-D Diagnosed Depression	26	6 (23.1%)	3 (11.5%)	3 (50.0%)	0.265
     CES-D					
     Total score	26	12.96 ± 10.06	9.08 ± 9.32	-3.88 ± 8.90	0.035
     I felt that I was just as good as other people	26	0.58 ± 0.86	0.46 ± 0.76	-0.12 ± 0.77	0.449
     I felt hopeful about the future	26	0.62 ± 0.85	0.65 ± 0.94	0.04 ± 1.22	0.873
     I was happy	26	0.81 ± 0.90	0.46 ± 0.58	-0.35 ± 0.80	0.036
     I enjoyed life	26	0.85 ± 0.88	0.42 ± 0.64	-0.42 ± 0.76	0.009
Big BMI loss group (lost over 12.20 points)					
     BMI	25	48.65 ± 5.66	33.50 ± 5.51	-15.14 ± 3.02	<0.001
					
     Total ESS	25	7.24 ± 5.47	6.12 ± 4.53	-1.14 ± 5.09	0.137
					
     CES-D Diagnosed Depression	25	9 (36.0%)	4 (16.0%)	5 (55.6%)	0.057
     CES-D					
     Total score	25	11.32 ± 8.21	9.24 ± 8.70	-2.08 ± 8.30	0.222
     I felt that I was just as good as other people	25	0.60 ± 1.04	0.56 ± 0.77	-0.04 ± 1.24	0.873
     I felt hopeful about the future	25	0.88 ± 1.12	0.68 ± 0.99	-0.20 ± 1.44	0.495
     I was happy	25	0.72 ± 0.94	0.44 ± 0.82	-0.28 ± 0.79	0.090
     I enjoyed life	25	0.76 ± 0.97	0.40 ± 0.76	-0.36 ± 0.81	0.036
In the small BMI loss group, participants had significant decreases in daytime sleepiness (m=-1.30±3.20, p=0.049), total CES-D score (m=-3.88±8.90, p=0.035), and the CES-D individual items of "I was happy" (m=-0.35±0.80, p=0.036) and "I enjoyed life" (m=-0.42±0.76, p=0.009). Using the CES-D at baseline, 6 (23.1%) of participants met the diagnosis criterion for depression, which reduced to 3 (11.5%) participants at their follow-up. Using the ESS at baseline, 6 (23.1%) scored 10 or higher, an indication of significant issues with daytime sleepiness. At the follow-up, this number dropped to 5 (19.2%). The highest ESS score at follow-up was 16 whereas the highest score at baseline was 17.
In the bigger loser group, only the CES-D individual items "I enjoyed life" had a significant decrease (m=-0.36±0.81, p=0.036). Marginally significant decreases were found in total participants who met the CES-D criterion for depression diagnosis (p=0.057) and the CES-D individual item "I was happy" (m=-0.28±0.79, p=0.090). Using the CES-D at baseline, 9 (36.0%) participants met the criterion for depression, which reduced to 4 (16.0%) participants at their follow-up. Using the ESS at baseline, 8 (32.0%) scored 10 or higher. At the follow-up, this number dropped to 6 (24.0%). The highest ESS score at follow-up was 16 whereas the highest score at baseline was 21.
Linear regression (Table 4) was used in the initial analysis of the relationships of BMI, daytime sleepiness, and depressive symptoms. Controlling for baseline BMI, age, and race, change in BMI from baseline to follow-up was found to not be a significantly related to change in depressive symptom score (p=0.558) or of change in daytime sleepiness score (p=0.274). Change in daytime sleepiness was found to be a significantly related to change in depressive symptom score (p=0.042). Since change in BMI was found to not significantly related to change in depressive symptom score and change in daytime sleepiness, the possibility of daytime sleepiness acting as a mediator for BMI and depressive symptoms was ruled out.
4.0 	discussion
After bariatric surgery, participants had significant decreases in BMI, daytime sleepiness, and total depressive symptoms. Looking more in depth at the CES-D individual items, participants indicated that they were happier and enjoyed life more after bariatric surgery. Although not statistically significant, there was a noticeable drop in the number, and percentage, of participants who would be categorized as depressed based on the CES-D scale, showing overall reduction of depressive symptoms after bariatric surgery, regardless of the amount of weight lost.
When participants were split into separate groups based on the amount of BMI lost, there were more statistically significant differences found in those the small BMI loss group (those who lost less weight) when compared to the big BMI loss group (those who lost more weight). Although there were more statistically significant differences in the small BMI loss group, the effect of bariatric surgery on daytime sleepiness and depressive symptoms were reflective of the basic findings. Regardless of the number of BMI points (or amount of weight lost), bariatric surgery aids in the alleviation of daytime sleepiness and depressive symptoms.
With the growing burden of obesity, there is a greater need to understand the underlying mechanisms of factors that can aggravate obesity. Bariatric surgery significantly reduced daytime sleepiness and depressive symptoms, which are commonly associated with aggravating BMI via eating habits and reduced activity.21 These results have confirmed what has been found in other studies, ADDIN EN.CITE ,, but this particular study focused for the first time in the literature on obese women who underwent bariatric surgery as well as looking at BMI, daytime sleepiness, and depressive symptoms altogether.
One particular limitation of this study is that this is a preliminary analysis of a subsample from an ongoing study and has a modest sample size and follow-up points. Although the mediation effect was not present in these data, that may in part be attributable to the modest sample size. Another limitation was that some of the data were missing, such as anthropometric data acquired from the Tanita scale, which made it more difficult to identify significant results. 
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